<--- Back to Details
First PageDocument Content
Immune system / Cell biology / Granulocytes / Basophil / Interleukin / Immunoglobulin E / Haematopoiesis / Neutrophil / Histamine / HOXB8 / White blood cell / Basophil activation
Date: 2015-10-11 11:12:58
Immune system
Cell biology
Granulocytes
Basophil
Interleukin
Immunoglobulin E
Haematopoiesis
Neutrophil
Histamine
HOXB8
White blood cell
Basophil activation

No. 55 A publication of the 3R Research Foundation Switzerland October 2015

Add to Reading List

Source URL: www.forschung3r.ch

Download Document from Source Website

File Size: 653,01 KB

Share Document on Facebook

Similar Documents

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

DocID: 1rgTJ - View Document

SuppreMol_Crawford Release ENG_Mar 4, 2015

SuppreMol_Crawford Release ENG_Mar 4, 2015

DocID: 1qGKf - View Document

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

DocID: 1qDqa - View Document

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche  Dr. Oliver Horlacher

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche Dr. Oliver Horlacher

DocID: 1qxAK - View Document

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

DocID: 1qs00 - View Document